Market Place
Sourcing Support
Pneumagen Neumifil Influenza Data: Positive
23 May 2024 //
GLOBENEWSWIRE
Pneumagen: Neumifil Phase 2 Antiviral Data At ATS 2024
02 May 2024 //
GLOBENEWSWIRE
Pneumagen Announces Successful Clinical Proof of Concept for Neumifil
02 Oct 2023 //
GLOBENEWSWIRE
Pneumagen raises £8m to accelerate Phase 2 clinical development of Neumifil
01 Jun 2023 //
GLOBENEWSWIRE
Pneumagen further strengthens IP protection for lead product Neumifil
18 Apr 2023 //
GLOBENEWSWIRE
Pneumagen Creates Advisory Group Leading Infectious Disease Experts
28 Sep 2022 //
PRNEWSWIRE
Pneumagen Begins Dosing in PII Proof of Concept Influenza Challenge Study
16 Aug 2022 //
PRNEWSWIRE
Pneumagen Announces Positive Top Line Results from PI Study Evaluating Neumifil
12 May 2022 //
PRNEWSWIRE
Pneumagen Announces Appointment of John Beadle as Non-Executive Director
09 May 2022 //
PRNEWSWIRE
Pneumagen Raises £3.8M to Advance the Phase II Clinical Development of Neumifil
19 Jan 2022 //
PRNEWSWIRE
Pneumagen Announces Neumifil™ is Efficacious In COVID-19 Infection
08 Mar 2021 //
PHARMIWEB
Pneumagen Announces £2.5m fundraising to advance universal treatment for viral
21 Jan 2021 //
PRNEWSWIRE
Pneumagen Announces £2.5m fundraising to advance universal treatment
20 Jan 2021 //
PRNEWSWIRE
Pneumagen Announces £4m Fundraising and Commits to Trial Devp for COVID-19
27 May 2020 //
PRNEWSWIRE
Pneumagen Announces Positive Anti-Viral Activity for Novel Glycan Approach
27 Apr 2020 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.